Member AUM
$80 trillion
glyph/search
Logout
Login
Sign Up
glyph/search
Tools
Engagements
Policy
Investor Statements
Resource Library
Themes
News & Events
About
Home
Resource Library
Companies Assessed
Dechra Pharmaceuticals
Downloads
Dechra Pharmaceuticals
LSE:DPH GB0009633180
Follow
Log in to be able to follow
Key Information
HQ:
United Kingdom
Market Cap:
$4.79bn
Primary Markets:
Europe & Russia, North America
Downloads
Company Info
Animal Pharmaceuticals Engagement
Downloads
glyph/search
Filter by:
Year
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Project Type
Alternative Proteins Framework
Animal Pharmaceuticals Engagement
Antibiotics Stewardship Engagement
Coller FAIRR Climate Risk Tool
Coller FAIRR Protein Producer Index
Coller FAIRR Protein Producer Index - Supply Chain Analysis
Company Focus
General FAIRR Assets
Meat Sourcing Engagement
Policy Consultations
Policy White Paper
Protein Diversification Engagement
Regenerative Agriculture
Research
Restaurant Antibiotics Engagement
Seafood Traceability Engagement
Sustainable Aquaculture Engagement
Sustainable Proteins Engagement
Waste & Pollution Engagement
Working Conditions Engagement
Theme/Topic
Alternative Proteins
Animal Welfare
Antibiotics & Health
Aquaculture
Biodiversity
Climate
Deforestation
Multiple themes
Social Risk
Waste & Pollution
Working Conditions
Content Type
Assessment
Company Response
Consultation
Datasheet
Engagement Letter
Factsheet
Investor Briefing
Investor Letter
Meeting Notes
Methodology
Report
Technical Annex
Terms of Reference
Video
Date
Description
Project Type
Key Topic
Content Type
May
2024
Log in to be able to follow
Dechra Pharmaceuticals Phase 2 Assessment
Animal Pharmaceuticals Engagement
Antibiotics & Health
Assessment
Log in to be able to follow
May
2023
Log in to be able to follow
Dechra Pharmaceuticals PLC Assessment
Animal Pharmaceuticals Engagement
Antibiotics & Health
Assessment
Log in to be able to follow